
GSK and Moderna settle patent dispute over COVID and RSV vaccines
GSK (GSK) and Moderna (MRNA) have settled lawsuits alleging that Moderna’s COVID-19 vaccines Spikevax and mNEXSPIKE, and its RSV shot mResvia, infringed the British drugmaker’s patents. Moderna said it settled GSK’s patent litigation in…